These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 10083500)
1. Are renal transplant recipients on CsA-based immunosuppressive regimens more likely to develop skin cancer than those on azathioprine and prednisolone? Jensen P; Hansen S; Møller B; Leivestad T; Pfeffer P; Fauchald P Transplant Proc; 1999; 31(1-2):1120. PubMed ID: 10083500 [No Abstract] [Full Text] [Related]
3. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients? Gjersvik P; Hansen S; Møller B; Leivestad T; Geiran O; Simonsen S; Pfeffer P; Fauchald P Transpl Int; 2000; 13 Suppl 1():S380-1. PubMed ID: 11112037 [TBL] [Abstract][Full Text] [Related]
4. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Glover MT; Deeks JJ; Raftery MJ; Cunningham J; Leigh IM Lancet; 1997 Feb; 349(9049):398. PubMed ID: 9033469 [No Abstract] [Full Text] [Related]
5. Triple therapy and incidence of de novo cancer in renal transplant recipients. Kehinde EO; Petermann A; Morgan JD; Butt ZA; Donnelly PK; Veitch PS; Bell PR Br J Surg; 1994 Jul; 81(7):985-6. PubMed ID: 7922092 [TBL] [Abstract][Full Text] [Related]
6. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. Jensen P; Hansen S; Møller B; Leivestad T; Pfeffer P; Geiran O; Fauchald P; Simonsen S J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):177-86. PubMed ID: 10025742 [TBL] [Abstract][Full Text] [Related]
7. Influence of immunosuppressive therapy on infectious complications in renal transplant recipients. Klauser R; Zlabinger GJ; Traindl O; Franz M; Watschinger B; Pohanka E; Kudlacek S; Kovarik J Transplant Proc; 1992 Feb; 24(1):292-4. PubMed ID: 1539284 [No Abstract] [Full Text] [Related]
8. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Kinlen LJ Am J Med; 1985 Jan; 78(1A):44-9. PubMed ID: 3970040 [TBL] [Abstract][Full Text] [Related]
9. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. Jensen P; Møller B; Hansen S J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):307. PubMed ID: 10642700 [No Abstract] [Full Text] [Related]
10. One thousand renal transplants at Belfast City Hospital: post-graft neoplasia 1968-1999, comparing azathioprine only with cyclosporin-based regimes in a single centre. McGeown MG; Douglas JF; Middleton D Clin Transpl; 2000; ():193-202. PubMed ID: 11512313 [TBL] [Abstract][Full Text] [Related]
11. Genetics and nonmelanoma skin cancer in kidney transplant recipients. Burke MT; Isbel N; Barraclough KA; Jung JW; Wells JW; Staatz CE Pharmacogenomics; 2015 Jan; 16(2):161-72. PubMed ID: 25616102 [TBL] [Abstract][Full Text] [Related]
12. Does mycophenolate mofetil increase the incidence of infections in renal transplant recipients? Prokopenko E; Scherbakova E; Vatazin A; Pasov S; Budnikova N; Agafonova S Drugs Exp Clin Res; 2005; 31(5-6):199-205. PubMed ID: 16425976 [TBL] [Abstract][Full Text] [Related]
13. Analysis of risk factors for cutaneous warts in renal transplant recipients. Barba A; Tessari G; Talamini G; Chieregato GC Nephron; 1997; 77(4):422-6. PubMed ID: 9434064 [TBL] [Abstract][Full Text] [Related]
14. Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation. Vos M; Plasmeijer EI; van Bemmel BC; van der Bij W; Klaver NS; Erasmus ME; de Bock GH; Verschuuren EAM; Rácz E J Heart Lung Transplant; 2018 Jul; 37(7):853-859. PubMed ID: 29680587 [TBL] [Abstract][Full Text] [Related]
15. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial. Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous complications in immunosuppressed renal homograft recipients. Koranda FC; Dehmel EM; Kahn G; Penn I JAMA; 1974 Jul; 229(4):419-24. PubMed ID: 4275980 [No Abstract] [Full Text] [Related]
17. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Dantal J; Hourmant M; Cantarovich D; Giral M; Blancho G; Dreno B; Soulillou JP Lancet; 1998 Feb; 351(9103):623-8. PubMed ID: 9500317 [TBL] [Abstract][Full Text] [Related]
18. Contribution of individual drugs to gingival overgrowth in adult and juvenile renal transplant patients treated with multiple therapy. Wilson RF; Morel A; Smith D; Koffman CG; Ogg CS; Rigden SP; Ashley FP J Clin Periodontol; 1998 Jun; 25(6):457-64. PubMed ID: 9667479 [TBL] [Abstract][Full Text] [Related]
19. Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance - the impact of immunosuppression on frequency of cSCC. Plasmeijer EI; Sachse MM; Gebhardt C; Geusau A; Bouwes Bavinck JN J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():33-37. PubMed ID: 31833604 [TBL] [Abstract][Full Text] [Related]
20. Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation. Marcén R; Galeano C; Fernández-Rodriguez A; Jiménez-Alvaro S; Teruel JL; Rivera M; Burgos FJ; Quereda C Transplant Proc; 2010 Oct; 42(8):3055-7. PubMed ID: 20970609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]